The company was established in Shanghai International Medical Park Medical Valley Park on August 31, 2010. In order to meet the treatment needs of patients with tachyarrhythmia, the company has always insisted on innovation and breakthroughs in core technology since its establishment. After more than ten years of continuous innovation, the company has completed a comprehensive product layout covering cardiac electrophysiological surgery. It is the first domestic manufacturer that can provide a complete solution for 3D cardiac electrophysiology equipment and consumables, and has achieved a collaborative layout of the three mainstream ablation energy products of “radiofrequency+freezing+pulse”. On August 31, 2022, the company was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The company is a high-tech enterprise focusing on R&D, production and sales of innovative medical devices in the field of electrophysiological interventional diagnosis and ablation treatment. The company's main products include standard measurement equipment, standard measurement catheters, three-dimensional ablation catheters, two-dimensional ablation catheters, cryoablation series, ablation treatment equipment, and accessory products. The company won the 2021 Shanghai Science and Technology Little Giant Enterprise, the 2021 Shanghai May 1st Labor Award, and the 2021 Shanghai High-tech Enterprise Qualification.